Prescribing Considerations for Children with Intellectual Disabilities and Developmental Disabilities
This course is part of a series of courses delivered in partnership with the Special Olympics on the topic of intellectual and developmental disability.
To learn more about this topic and earn more free CE, visit Navigating Special Education Services for Children with Developmental Or Intellectual Disabilities and Transitioning Adolescents with Intellectual and Developmental Disability to Adult Care
Important: This continuing education activity is free. Please contact the National Association of Pediatric Nurse Practitioners national office at (877) 662-7627 to request assistance if needed.
Participants are forbidden to reproduce, republish, redistribute, or resell this course in any other form. For copyright-related questions, please email your question to: email@example.com.
Copyright © 2020 by the National Association of Pediatric Nurse Practitioners.
This continuing education activity is administered by the National Association of Pediatric Nurse Practitioners (NAPNAP) as an Agency providing continuing education credit. Individuals who complete this program and earn a 70% or higher score on the post test will be awarded 1.0 NAPNAP contact hours, of which 0 is pharmacology content.
Participants are forbidden to reproduce, republish, redistribute, or resell this course in any other form. For copyright-related questions, please email your question to: firstname.lastname@example.org
The National Association of Pediatric Nurse Practitioner discloses that this work is supported by Special Olympics through cooperative agreement #NU27DD001156 from the U.S. Centers for Disease Control and Prevention (CDC). The contents are the responsibility of the author and do not necessarily represent the views of Special Olympics or the CDC.”
Pediatric-focused advanced practice registered nurses
At the end of the session the learner will be able to:
1. Identify the current guidelines for the diagnosis of intellectual disorders (ID) and developmental disorders/autism (DD)
2. Integrate knowledge of the current evidence for the use of pharmacologic modalities for the treatment of mental health issues in children with ID and DD into primary care
3. Integrate knowledge of the current evidence for the management of sleep disorders in children with ID and DD into primary care.
Dawn Garzon Maaks PhD, CPNP-PC, PMHS, FAAN, FAANP
University of Portland
School of Nursing
• I have no personal disclosures
• This discussion includes non-FDA approved therapies
- 1.00 Contact hours